Journal profile · Clinical Neurology
Neurogenetics
ISSN 1364-6745 · eISSN 1364-6753 · Springer Berlin Heidelberg · GERMANY · Quarterly · Founded 1997
Neurogenetics: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.61; hybrid open access; APC about USD 4,590; median 98 days to acceptance (104 articles, last 24 months); community-reported acceptance: about 95%; 76 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Neurogenetics is published by Springer Berlin Heidelberg and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Genetic Neurodegenerative Diseases, Hereditary Neurological Disorders and Neurological diseases and metabolism, together about 28.7% of its articles. Its main subfields are Genetics. (generated from OpenAlex topic counts and CAS ranking data)
Neurogenetics publishes findings that contribute to a better understanding of the genetic and epigenetic regulation of nervous system development and function, as well as of brain dysfunction. In addition to Neurogenetic disorders, studies addressing the genetic or epigenetic basis of neurodevelopmental, neuropsychiatric and neurodegenerative diseases are the main focus of the journal. Thereby, in addition to neurons, studies investigating the role of glia cells in these diseases are welcome. Neurogenetics therefore includes findings in humans and other organisms that help understand neurological disease mechanisms and publishes papers from many different fields such as biophysics, cell biology, human genetics, neuroanatomy, neurochemistry, neurology, neuropathology, neurosurgery and psychiatry. Neurogenetics is published in hardcopy and online. It includes Review Articles, Original Articles, Short Communications and Letters to the Editors on the field of neurogenetics and neuroepigenetics. Well-powered studies reporting negative results are also welcome. Past Editors-in-Chief Georg W. J. Auburger, Experimental Neurology, Medical Faculty, Johann-Wolfgang-Goethe University Manuel B. Graeber, Barnet-Cropper Chair of Brain Tumour Research, The Brain and Mind Research Institute, University of Sydney Louis J. Ptáček, Department of Neurology, University of California, San Francisco Eric P. Hoffman, School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, United States of America James R. Lupski, Baylor College of Medicine, Houston, TX, United States of America Ulrich Müller, Justus Liebig University, Gießen, Germany Founding Editors Ulrich Müller Manuel B. Graeber Eric P. Hoffman
From the journal's Aims & Scope
Research area (LetPub): Clinical Neurology
Editor-in-chief Silvia De RubeisPublisher website
Editorial board by country: none in mainland China; most named United States 14, Germany 9, United Kingdom 3, France 2, Italy 2 (34 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Genetic Neurodegenerative DiseasesNeuroscience11.1%
- Hereditary Neurological DisordersNeuroscience9.1%
- Neurological diseases and metabolismNeuroscience8.5%
- Mitochondrial Function and PathologyBiochemistry, Genetics and Molecular Biology8.2%
- Genetics and Neurodevelopmental DisordersBiochemistry, Genetics and Molecular Biology7.4%
- Parkinson's Disease Mechanisms and TreatmentsMedicine5.1%
- RNA regulation and diseaseBiochemistry, Genetics and Molecular Biology5%
- Genomics and Rare DiseasesBiochemistry, Genetics and Molecular Biology4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.61LetPub ·
- Impact factor (publisher) 2025
- 1.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.8Publisher website ·
- CiteScore 2026-06
- 2.4LetPub ·
- SJR 2026-06
- 0.7LetPub ·
- SNIP 2026-06
- 0.88LetPub ·
- h-index
- 56LetPub ·
- h-index
- 83OpenAlex ·
- i10-index
- 730OpenAlex ·
- 2-year mean citedness
- 1.96OpenAlex ·
- Self-citation rate
- 6.2%LetPub ·
- Share of gold OA articles
- 17.42%LetPub ·
Volume
- Articles per year
- 72LetPub ·
- Downloads per year (publisher) 2025
- 209,600Publisher website ·
Articles by year OpenAlex count · 1,228 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 72 | 20 | 7 |
| 2025 | 76 | 17 | 187 |
| 2024 | 54 | 12 | 202 |
| 2023 | 34 | 12 | 121 |
| 2022 | 28 | 8 | 192 |
| 2021 | 50 | 24 | 513 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
98 daysMedian, submission to acceptance · P25–P75 66 days – 131 days
- Acceptance to online
- median 15 days (104 articles)
- Submission to online
- median 115 days
- Sample
- 104 articles with submission and acceptance dates (159 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 6 monthsLetPub ·
- Average acceptance (community reports)
- 95%LetPub ·
- Submission to first decision
- 8 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,590 / EUR 3,590 / GBP 2,890 | — | — | |
| Publisher website | No APC | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Required
Article types accepted17, with length limits
- author's viewAuthor's View articles are short and focused opinions or commentaries by researchers on their research paper(s) recently published in the field(s) of neurogenet…Length not stated
- commentComment: This section is reserved for the publication of important preliminary novel findings and for the discussion of controversial issues.Length not stated
- commentaryOriginal Articles: There is no length limit or restriction on the number of illustrations/tables for full-length articles. However, authors are encouraged to av…Length not stated
- editorialIt is understood that by publishing a paper in Neurogenetics, the authors agree to make available to colleagues in academic (nonprofit) research any of the cell…Length not stated
- letterOriginal Articles: There is no length limit or restriction on the number of illustrations/tables for full-length articles. However, authors are encouraged to av…Length not stated
- meta-analysisOriginal Articles: There is no length limit or restriction on the number of illustrations/tables for full-length articles. However, authors are encouraged to av…Length not stated
- opinionOriginal Articles: There is no length limit or restriction on the number of illustrations/tables for full-length articles. However, authors are encouraged to av…Length not stated
- original articleOriginal Articles: There is no length limit or restriction on the number of illustrations/tables for full-length articles. However, authors are encouraged to av…Length not stated
- original articlesOriginal Articles: There is no length limit or restriction on the number of illustrations/tables for full-length articles.Length not stated
- research paperOriginal Articles: There is no length limit or restriction on the number of illustrations/tables for full-length articles. However, authors are encouraged to av…Length not stated
- reviewOriginal Articles: There is no length limit or restriction on the number of illustrations/tables for full-length articles. However, authors are encouraged to av…Length not stated
- review articleOriginal Articles: There is no length limit or restriction on the number of illustrations/tables for full-length articles. However, authors are encouraged to av…Length not stated
- review articlesReview Articles: Review Articles and mini-reviews are most welcome.Length not stated
- short communicationOriginal Articles: There is no length limit or restriction on the number of illustrations/tables for full-length articles. However, authors are encouraged to av…main text ≤ 1,200 words
- short communicationsShort Communications of up to 1,200 words (excluding references and abstract) should be submitted in the format of a short paper.Length not stated
- spotlightsSpotlights are always commissioned directly by the Editors-in-Chief.Length not stated
- systematic reviewOriginal Articles: There is no length limit or restriction on the number of illustrations/tables for full-length articles. However, authors are encouraged to av…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Preprints, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
Variants must be submitted to a public database Model summary
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Neurogenetics, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Authors recommend 5-6 reviewers Model summary
Authors are asked to recommend names (with contact email) for 5-6 experts in the field that they feel would be good reviewers for this manuscript.
Source ↗Publisher website ·- Preprints
Does not publish negative results Model summary
Neurogenetics does not publish negative results.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Berlin Heidelberg
- Country or region
- GERMANY
- Language
- English
- Frequency
- Quarterly
- Founded
- 1997
- ISSN
- 1364-6745
- Electronic ISSN
- 1364-6753
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Neurogenetics
What CAS zone is Neurogenetics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Neurogenetics is in Zone 4 of Medicine, and in Zone 4 of the minor category Clinical Neurology / Genetics & Heredity. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Neurogenetics?
The latest impact factor listed by LetPub is 1.61; CiteScore 2.4, h-index 83.
How long does peer review take at Neurogenetics?
Based on the dates recorded on 104 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 98 days (interquartile range 66–131 days); authors report an average review time of about 6 months; the community-reported acceptance is “about 95%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Neurogenetics?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Neurogenetics based?
Of the 34 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (14), Germany (9) and United Kingdom (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Neurogenetics?
According to LetPub and DOAJ records, Neurogenetics is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is Neurogenetics open access, and what is the APC?
Neurogenetics is a hybrid journal. For open-access publication: APC about USD 4,590.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .